Clinical trial
Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the…
NCT00003054 · Gynecologic Oncology Group, Other · Terminated
Key facts
| NCT number | NCT00003054 |
|---|---|
| Title | Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus |
| Official title | Evaluation of Paclitaxel (Taxol) in the Treatment of Recurrent or Persistent Leiomyosarcoma of the Uterus |
| Lead sponsor | Gynecologic Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Drug |
| Interventions | paclitaxel |
| Start date | Aug 1, 1997 |
| Primary completion | Jul 1, 2002 |
| First posted | Jun 25, 2003 |
| Last update posted | Apr 12, 2018 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: